- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 03.12. | Universal Ibogaine Inc.: Universal Ibogaine advises further on application for Management Cease Trade Order | 2 | TheNewswire | ||
| 26.11. | Universal Ibogaine Inc: Universal Ibogaine applies for MCTO | 7 | Stockwatch | ||
| UNIVERSAL IBOGAINE Aktie jetzt für 0€ handeln | |||||
| 25.11. | Universal Ibogaine Inc.: Universal Ibogaine Advises of Filing Application for Management Cease Trade Order | 4 | TheNewswire | ||
| 28.10. | Universal Ibogaine Inc: Universal Ibogaine "temporarily" closes Kelburn | 19 | Stockwatch | ||
| 28.10. | Universal Ibogaine Inc.: Universal Ibogaine Provides Corporate Update | 11 | TheNewswire | ||
| 24.09. | Universal Ibogaine Inc: Universal Ibogaine board lists five directors | 32 | Stockwatch | ||
| 23.09. | Universal Ibogaine Inc.: Universal Ibogaine Announces Board Changes | 10 | TheNewswire | ||
| 15.09. | Universal Ibogaine Inc: Universal Ibogaine shareholders vote down two matters | 4 | Stockwatch | ||
| 15.09. | Universal Ibogaine Inc.: Universal Ibogaine Announces Results of the Annual Meeting of Shareholders | 15 | TheNewswire | ||
| 05.09. | Universal Ibogaine Inc. provides update on intent to file Clinical Trial Application with Health Canada and confirms securing of Ibogaine drug supply | 17 | TheNewswire | ||
| 04.09. | Universal Ibogaine Inc: Universal Ibogaine adds Killebrew, Wagner as directors | 13 | Stockwatch | ||
| 03.09. | Universal Ibogaine Inc.: Universal Ibogaine advises of appointment of two new Board Members | 4 | TheNewswire | ||
| 17.07. | Universal Ibogaine Inc: Universal Ibogaine CFO Leavens resigns | 10 | Stockwatch | ||
| 17.07. | Universal Ibogaine announces CFO departure | 13 | Seeking Alpha | ||
| 17.07. | Universal Ibogaine Inc.: Universal Ibogaine advises of departure of CFO | 3 | TheNewswire | ||
| 08.07. | Universal Ibogaine Inc: Universal Ibogaine director Cranwill resigns | 14 | Stockwatch | ||
| 08.07. | Universal Ibogaine Inc.: Universal Ibogaine Advises of Debt Settlement with CEO and Resignation of a Member of its Board of Directors | 5 | TheNewswire | ||
| 08.07. | Universal Ibogaine Inc: Universal Ibogaine 4,248,000 shares for debt | 2 | Stockwatch | ||
| 10.04. | XFRA JC4: WIEDERAUFNAHME/RESUMPTION | 334 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 04.02. | XFRA JC4: AUSSETZUNG/SUSPENSION | 415 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILUNIVERSAL IBOGAINE... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SANOFI | 82,87 | -0,26 % | BERNSTEIN RESEARCH stuft SANOFI auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Sanofi nach dem Auftritt des Finanzchefs auf einer Bernstein-Konferenz auf "Outperform" mit einem Kursziel... ► Artikel lesen | |
| CANOPY GROWTH | 0,989 | +0,51 % | Canopy USA: Wana Brands Launches THC Gummies in Switzerland Through Pioneering Pilot Program | Wana Brands, North America's leading edibles provider and a subsidiary of Canopy USA LLC ("Canopy USA"), announced today that the brand is launching its premium gummies in Zürich, Switzerland as... ► Artikel lesen | |
| ASTRAZENECA | 155,25 | -0,13 % | BERNSTEIN RESEARCH stuft ASTRAZENECA auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Astrazeneca nach einem Treffen mit dem Onkologie-Chef für Europa und Kanada auf "Outperform" mit einem Kursziel... ► Artikel lesen | |
| INNOCAN PHARMA | 6,000 | 0,00 % | Innocan Pharma gibt Finanzergebnisse für 3. Quartal 2025 bekannt - mit Umsätzen von 21,6 Mio. USD | Herzliya, Israel und Calgary, Alberta - 27. November 2025 / IRW-Press / Innocan Pharma Corporation (CSE: INNO) (FWB: IP4) (OTC: INNPF) (das
"Unternehmen" oder "Innocan"), ein pharmazeutisches... ► Artikel lesen | |
| ZOETIS | 100,44 | +0,84 % | Zoetis Stock Plummets 24.8% YTD: Here's What You Need to Know | ||
| IONIS PHARMACEUTICALS | 67,62 | -0,29 % | Ionis Pharmaceuticals stock maintains Buy rating at TD Cowen on growth outlook | ||
| HAPPY BELLY FOOD GROUP | 1,220 | +2,52 % | Happy Belly Food Group Inc.: Happy Belly Food Group Announces Executive Leadership Plan to Support Next Phase of Growth | Toronto, Ontario--(Newsfile Corp. - December 8, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands... ► Artikel lesen | |
| CSPC PHARMA | 0,814 | -1,64 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - NMPA ACCEPTS SECOND MARKETING AUTHORISATION APPLICATION FOR SEMAGLUTIDE INJECTION | ||
| ALTIMMUNE | 4,840 | +2,22 % | Altimmune, Inc: Altimmune Announces CEO Transition and Succession Plan | Jerry Durso, accomplished industry leader, to succeed Vipin Garg, Ph.D. as Chief Executive Officer Transition follows seven years of strong leadership by Dr. Garg GAITHERSBURG, Md., Dec. 01, 2025... ► Artikel lesen | |
| CATALYST PHARMACEUTICALS | 19,460 | +0,36 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update | Reported Q3 2025 Total Revenues of $148.4 Million, Driven by Continued FIRDAPSE® Growth, Strong AGAMREE® Uptake and Growth, and Continued Demand for FYCOMPA® Raising Full-Year 2025 Total Revenue Guidance... ► Artikel lesen | |
| AVADEL PHARMACEUTICALS | 18,400 | 0,00 % | Avadel Pharmaceuticals plc: Announcement relating to despatch of Rule 15 proposal | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.... ► Artikel lesen | |
| NUMINUS WELLNESS | 0,027 | -100,00 % | Numinus Wellness Inc.: Numinus Wellness Provides Corporate Update | Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative... ► Artikel lesen | |
| ELANCO ANIMAL HEALTH | 17,710 | +0,71 % | Elanco cuts hundreds of jobs targeting up to $250M in savings by 2030 | ||
| ONO PHARMACEUTICAL | 11,900 | +1,71 % | Ono Pharmaceutical H1 Results Improve; Backs Annual Guidance | TOKYO (dpa-AFX) - Ono Pharmaceutical Co., Ltd.(OPHLF, 4528.T) on Thursday reported a rise in earnings and revenue for the first half. In addition, the company has reaffirmed its annual outlook.For... ► Artikel lesen | |
| IANTHUS CAPITAL | 0,001 | 0,00 % | iAnthus Capital Holdings, Inc.: iAnthus Continues Expansion in Florida with the Opening of GrowHealthy's 25th Dispensary in St. Petersburg |
Das Unternehmen UNIVERSAL IBOGAINE INC kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell -80,00 % bei einem Aktienkurs von 0,001 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu UNIVERSAL IBOGAINE INC finden Sie auf Wallstreet Online.